Celldex Therapeutics Shares Down 14.3% Since SmarTrend's Sell Call (CLDX)
January 12, 2016 at 17:54 PM EST
SmarTrend identified a Downtrend for Celldex Therapeutics (NASDAQ:CLDX) on December 14th, 2015 at $14.17. In approximately 4 weeks, Celldex Therapeutics has returned 14.30% as of today's recent price of...